An expert review of quadruple therapy for heart failure and the critical significance of promptly initiating these guideline-directed medications. Dr. Stephen Greene, Heart Failure Cardiologist and Assistant Professor of Medicine at the Duke Clinical Research Institute, reviews the evidence supporting simultaneous or rapid-sequence initiation of quadruple therapy to optimize patient care. Dr. Vanessa Blumer, Advanced Heart Failure and Transplant Cardiologist, Inova Schar and Vascular, moderates a post-presentation Q&A with Dr. Greene.
